Rofleponide palmitate

Rofleponide palmitate is a corticosteroid used in the treatment of asthma. It is a prodrug of budesonide, which means it is metabolized into the active drug budesonide in the body. Rofleponide palmitate is administered via inhalation, allowing it to directly target the lungs and reduce inflammation.

Pharmacology

Rofleponide palmitate is a prodrug, which means it is inactive until it is metabolized in the body. It is converted into its active form, budesonide, in the lungs. Budesonide is a potent corticosteroid that reduces inflammation in the airways, improving symptoms of asthma.

Clinical Use

Rofleponide palmitate is used in the treatment of asthma, a chronic condition characterized by inflammation and narrowing of the airways. It is administered via inhalation, which allows the drug to directly target the lungs and reduce inflammation. This can help to relieve symptoms such as wheezing, coughing, and shortness of breath.

Side Effects

As with all corticosteroids, rofleponide palmitate can have side effects. These may include throat irritation, hoarseness, and fungal infections of the mouth. It is important to rinse the mouth after using rofleponide palmitate to reduce the risk of these side effects.

See Also

• Corticosteroid
• Asthma
• Budesonide
• Prodrug

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian